Along similar observations, the inhibition of the methionine cycle rate-limiting enzyme, methionine adenosyltransferase 2A (MAT2A), which led to a block in methionine utilization, was useful in preventing cancer relapse [20]. The gene discussed is MAT2A; the disease is cancer.